Skip to content

Does the Negativation of the Glucose Hydrogen Breath Test Come Along With a Reduction of the Symptoms of Gaz Incontinence ?

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01275560
Enrollment
16
Registered
2011-01-12
Start date
2011-01-01
Completion date
2015-06-01
Last updated
2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal Incontinence

Brief summary

The objectives of this work are: 1/to estimate the frequency of a positive glucose breath test in favour of a small intestinal bacterial overgrowth in a population of patients consulting for gaz incontinence by comparison to a population of control subjects; 2/to estimate versus a conventional treatment the efficiency of an antibiotic treatment; in case of small intestinal bacterial overgrowth diagnosed by the glucose breath test, to improve gaz incontinence

Interventions

DRUGMetronidazole

Metronidazole,per os,500mg, 3 per day during 10 days

DRUGCArbosylane

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Gaz incontinence for more than 3 months * Afflilied to national health security * Having read and sign the information letter and consent form

Exclusion criteria

* Pregnancy * use of antibiotics, probiotics, IPP for less tha n 3 months * past of small intestinal bacterial overgrowth * ischemic, inflammatory colitis,colo-rectal cancer * diabetes * allergy to metronidazole * psychiatric disease * patients who do not speak or read french

Design outcomes

Primary

MeasureTime frame
number of gaz incontinence episodes3 days before randomization and treatement and 3 days after 10 days of treatment (antibiotic or conventionnal treatment

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026